We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
예정된 실적 발표입니다. 일정과 시장 기대치를 확인하세요.
US analyst rating / recommendation change.
신규 편입 · 포트폴리오 비중 0.00%
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
Consensus PT $18 · 2 analysts
Stored first · Google News · Yahoo Finance (English)
LONA Q1 2026 Earnings: Beats EPS Estimates Amidst Pre-Revenue Stage - Net Profit Margin - dars.gov.et
LONA Q1 2026 Earnings: Beats EPS Estimates Amidst Pre-Revenue Stage - Net Profit Margin dars.gov.et
LeonaBio Inc. (LONA) Gains 2.24% as Stock Approaches Key Resistance at $10.08 - Stop Loss Guidance - dars.gov.et
LeonaBio Inc. (LONA) Gains 2.24% as Stock Approaches Key Resistance at $10.08 - Stop Loss Guidance dars.gov.et
Form 4 LeonaBio Inc For: 10 July By Investing.com - Investing.com Nigeria
Form 4 LeonaBio Inc For: 10 July By Investing.com Investing.com Nigeria
LeonaBio (LONA) awards 28,000 stock options tied to Perceptive Advisors board role - Stock Titan
LeonaBio (LONA) awards 28,000 stock options tied to Perceptive Advisors board role Stock Titan
LeonaBio (LONA) director entities receive 28,000 stock options grant - Stock Titan
LeonaBio (LONA) director entities receive 28,000 stock options grant Stock Titan
LONA Q1 2026 Earnings: EPS Surprise of 32% Powers 5.85% Share Rally - Earnings Per Share - dars.gov.et
LONA Q1 2026 Earnings: EPS Surprise of 32% Powers 5.85% Share Rally - Earnings Per Share dars.gov.et
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 08. 06. | After market close (AMC) | — | — | — | $0 | — | Scheduled |
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 05. 27. | Piper Sandler | — | Initiate coverage | — → Overweight | — | Piper Sandler: Overweight |
| 2026. 02. 19. | Mizuho | — | Upgrade | Neutral → Outperform | — | Mizuho: Neutral → Outperform |
As of FY2026Q1 · Source: SEC/DART + price data
| # | Institution | Mandate | Shares | Value | Weight | Change | Position |
|---|---|---|---|---|---|---|---|
| 1 | TWO SIGMA INVESTMENTS, LP | TWO SIGMA INVESTMENTS, LP | 13,276 | $136.48K | 0.00% | — | New position |